Autoimmune Disease Clinical Trials in Shanghai, Shanghai Municipality
5 recruitingShanghai, Shanghai Municipality, China
Showing 1–5 of 5 trials
Recruiting
Early Phase 1
A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate to Severe Refractory Autoimmune Diseases
Moderate to Severe Refractory Autoimmune Diseases
Vivacta Biotechnology (Shanghai) Co., Ltd.22 enrolled1 locationNCT07614191
Recruiting
Early Phase 1
A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases
Moderate to Severe Refractory Autoimmune Disease
Grit Biotechnology22 enrolled1 locationNCT07333118
Recruiting
Phase 1
A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.
Autoimmune Disease
Changchun GeneScience Pharmaceutical Co., Ltd.48 enrolled1 locationNCT07366866
Recruiting
Phase 1
A Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases
Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.42 enrolled6 locationsNCT07049081
Recruiting
Phase 4
Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage
Postpartum HemorrhageSystemic Autoimmune Diseases
RenJi Hospital276 enrolled1 locationNCT06754371